15 Minutes Covid 19 Rapid Test Kit Nasal Specimen Nasopharyngeal Test Kit

Flowflex Clear 19 Rapid Antigen Home Test

A rapid test for the detection of antigens in anterior nasal specimens directly from individuals within 7 days of symptom onset.

A rapid test for the detection of antigens in anterior nasal specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect Clear 19 Rapid infection.

Qualitative detection of the nucleocapsid protein antigen from in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect Clear 19 Rapid infection.

This test is authorized for non-prescription home use with self-collected anterior nasal swab specimens directly from individuals aged 14 years and older or with adult-collected anterior nasal samples directly from individuals aged 2 years or older.

The Flowflex Clear 19 Rapid Antigen Home Test does not require serial testing.

• Easy-to-use nasal swab test
• Requires just 1 test*
• Can be used to test children as young as 2 years old
• For use with and without Clear 19 Rapid symptoms
• Results in 15 minutes
• No need to send off to a lab to obtain results
• Compact packaging for “On-The-Go” testing

*Other Clear 19 Rapid antigen home tests may require a 2nd test 2-3 days after the first.

Packing:

1 Test packing size: 56.5*39*36.5cm, 300 tests per box. G.W: 11.5KG

5 Test packing size: 52*39.5*44cm, 600 tests per box. G.W: 11.5KG

25 test packing size: 44.5*40*41cm, 600 tests per box. G.W: 12.2KG

Founded in 2011, Signo is a high-tech enterprise specializing in the development, production and sales of in vitro diagnostic reagents.
The company has established a strict quality management system and passed ISO9001: 2015 and ISO13485: 2016 international quality system certifications.

It has advanced international fully automatic production equipment, and the workshop is designed in strict accordance with standards and has reached 10,000-level purification standards. Signo has strong biotechnology power, and currently has more than 60 independent intellectual property rights, including 2 invention patents, and undertakes many provincial and municipal science and technology innovation projects.The products are mainly related to microorganisms / clinical reagents, medical equipment / robots, biochemical diagnostic reagents and so on. Signo's corporate purpose is to care for human health, develop a magnificent career in medical technology, and achieve a successful life. Guided by the ingenious product concept of pursuing perfection, the company is committed to providing disposable medical microbial culture media.The company continuously improves technology and develops new products according to market needs, and makes every effort to meet customer needs.